The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021.
Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021
Get Sample Copy Here@ www.reportsnreports.com/contacts/r…aspx?name=431843
This market is categorized on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.
Major factors contributing to the growth of the active pharmaceutical ingredients market include increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals. Government initiatives to encourage adoption of generics also provide an impetus for the growth of this market.
For instance, in 2008, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, launched the Jan Aushadhi Scheme (Public Medicine Scheme) for providing quality medicines to the masses at affordable prices.Under this initiative, the government set up Jan Aushadhi stores to provide generic drugs to patients.
Similarly, The European Union’s decentralized procedure (DCP) for drug approval is an effective system for cross-border collaboration on the authorization of medicines.
Access report at www.reportsnreports.com/contacts/d…aspx?name=431843
Active Pharmaceutical Ingredients Market, By Type of Drug
Active Pharmaceutical Ingredients Market, By Potency
Low to Moderate Potency Active Pharmaceutical Ingredients
Potent to Highly Potent Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients Market, By Therapeutic Application
Central Nervous System and Neurological Disorders
Other Therapeutic Applications
Fundamental from Table of Content
3 Executive Summaries
4 Premium Insights
4.1 Active Pharmaceutical Ingredients Market Overview
4.2 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
4.3 Active Pharmaceutical Ingredients Market, By Therapeutic Area
4.4 Biotech Active Pharmaceutical Ingredients Market, By Product
4.5 Active Pharmaceutical Ingredients Market, By Type of Drug
4.6 Active Pharmaceutical Ingredients Market: Geographic Snapshot
13 Company Profiles
(Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
13.2 Pfizer, Inc.
13.3 Novartis International AG
13.5 Boehringer Ingelheim
13.6 Bristol-Myers Squibb
13.7 Teva Pharmaceutical Industries Ltd.
13.8 ELI Lilly and Company
13.9 Glaxosmithkline PLC
13.10 Merck & Co., Inc.
13.11 Abbvie Inc.
*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
Browse Here for full Report with TOC: www.reportsnreports.com/reports/43…cast-to-2020.html